InterCure, Ltd. (TASE: INCR.TA), a life science company, announced a private fundraising of approx. NIS 45 Million, at a price per share of 4.45 NIS, reflecting a 37% premium to Intercure’s share price on the prior trading day on TASE.
November 6, 2018
· 2 min read